340B Advocacy Alliance Bulletin

A U.S. District Court for the District of Columbia judge today ruled against Johnson and Johnson and sided with the Department of Health and Human Services and hospitals in a lawsuit brought by J&J challenging the government’s authority to reject J&J’s proposed 340B rebate model.
The AHA on Thursday, May 15 at 3 p.m. ET will host a call for member hospitals and health systems to discuss the Department of Health and Human Services’ recent announcement that it will be “in a position to provide guidance” about the drug industry’s proposed use of “rebate models” by the end of…
The Administration releases executive order on drug pricing; read AHA’s statement.
The Department of Health and Human Services said its decision to prevent drug companies from implementing a 340B rebate model “was within its statutory authority,” according to a department brief filed with the United States District Court for the District of Columbia.